BIO Asia–Taiwan 2022 亞洲生技大會

BIO Asia–Taiwan 2022 亞洲生技大會

TEACHER

Hsing-Chen Tsai

Session 8 – Healthcare Innovation Strategy

Date:28 July (Thursday)
Time:  12:20 – 13:50 (GMT+8)

Hsing-Chen Tsai

Assistant Professor/Attending Physician
National Taiwan University

Dr. Hsing-Chen Tsai is a pulmonologist at National Taiwan University Hospital and an assistant professor at National Taiwan University. She received her medical degree from National Taiwan University and doctoral degree (Ph.D.) in Cellular and Molecular Medicine from Johns Hopkins University. As a physician-scientist, Dr. Tsai devotes her time and efforts to patient care and biomedical research, focusing on diagnostic and therapeutic applications of epigenetic regulatory processes in cancer and its immune microenvironment. She leads several innovative research projects in collaboration with various academic institutions and international pharmaceutical companies, including Johnson & Johnson. Dr. Tsai has received many prestigious awards such as the 18th National Innovation Award and the NTUH outstanding research award for her research achievements. Her current research directions include: 1) Developing epigenetic strategies to enhance the therapeutic efficacy of γδ T-based cellular immunotherapy, 2) Pharmacologically modulating epigenetic mechanisms to reverse T cell exhaustion, and 3) Identifying novel circulating methylated markers in lung cancer patients for early diagnosis. In addition to her research efforts, Dr. Tsai serves as deputy director of NTUH Center for Frontier Medicine to help bridge laboratory discoveries and clinical applications in regenerative medicine, cellular immunotherapy and gene therapy.
 

Speech title & Synopsis

Panel Discussion: Accelerating Innovation Through External Collaboration